POLLICITA, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 6.445
EU - Europa 676
AS - Asia 106
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.232
Nazione #
US - Stati Uniti d'America 6.442
SE - Svezia 220
DE - Germania 99
UA - Ucraina 88
CN - Cina 70
IT - Italia 59
IE - Irlanda 55
FR - Francia 50
PL - Polonia 45
KR - Corea 22
GB - Regno Unito 20
FI - Finlandia 19
RU - Federazione Russa 12
BE - Belgio 7
SG - Singapore 4
VN - Vietnam 3
CA - Canada 2
TR - Turchia 2
CL - Cile 1
DM - Dominica 1
ES - Italia 1
EU - Europa 1
ID - Indonesia 1
IN - India 1
JP - Giappone 1
KZ - Kazakistan 1
MN - Mongolia 1
NG - Nigeria 1
NL - Olanda 1
PE - Perù 1
ZA - Sudafrica 1
Totale 7.232
Città #
Woodbridge 1.906
Wilmington 1.672
Houston 1.634
Ann Arbor 185
Chandler 179
Fairfield 175
Ashburn 85
Jacksonville 80
Cambridge 75
Seattle 69
Dublin 55
Dearborn 44
Kraków 44
Medford 42
Beijing 32
Lawrence 19
Rome 16
Mülheim 15
Boardman 13
Milan 13
Zhengzhou 13
San Diego 10
Menlo Park 9
New York 8
Brussels 7
Colorado Springs 5
Cagliari 4
Norwalk 4
Creede 3
Hefei 3
Jinan 3
Kunming 3
Palo Alto 3
Phoenix 3
San Mateo 3
Shanghai 3
University Park 3
Verona 3
Binasco 2
Dong Ket 2
Guangzhou 2
Hebei 2
Indiana 2
Kilburn 2
London 2
Potenza 2
Redwood City 2
Saint Petersburg 2
Yellow Springs 2
Almaty 1
Andover 1
Den Burg 1
Dobong-gu 1
Falls Church 1
Hanover 1
Helsinki 1
Ho Chi Minh City 1
Islington 1
Jakarta 1
Lagos 1
Lima 1
Magenta 1
Markham 1
Nanjing 1
Nanning 1
Ningbo 1
North Hollywood 1
Novokuznetsk 1
Nürnberg 1
Pescantina 1
Philadelphia 1
Quzhou 1
Roseau 1
San Francisco 1
Seoul 1
Shaoxing 1
Southwark 1
Tappahannock 1
Toronto 1
Uppsala 1
Washington 1
Wenzhou 1
Totale 6.498
Nome #
Therapeutic strategies towards HIV-1 infection in macrophages 464
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 445
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 437
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 433
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 431
Nucleotide polymorphisms in the 5'-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype 427
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 419
HIV-1-associated dementia during HAART therapy 408
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 390
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: Evaluation of new 6-desfluoroquinolone derivatives 388
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 382
Key patterns of HBX and pre-S1/S2 mutations are involved in mechanisms underlying HBV-induced hepatocellular carcinoma in vivo 375
Comparative replication capacity of raltegravir-resistant strains and antiviral activity of the new-generation integrase inhibitor dolutegravir in human primary macrophages and lymphocytes 372
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line 366
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 353
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA Study Group 340
Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells 303
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages 261
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 155
New classes of anti-HIV-1 compounds active at different stages of infection 108
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 16
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 16
Totale 7.289
Categoria #
all - tutte 12.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019383 0 0 0 0 0 0 0 0 0 0 204 179
2019/20201.982 174 183 134 193 169 227 182 166 155 152 113 134
2020/20211.171 120 132 152 138 108 120 173 96 24 38 41 29
2021/2022310 17 10 94 18 6 25 8 3 40 28 7 54
2022/2023383 25 41 6 63 38 78 21 30 37 14 27 3
2023/202483 16 9 7 2 14 19 2 12 0 0 2 0
Totale 7.289